History Selegiline
emsam transdermal patch, 6mg/24hr dose
in 1990s, j. alexander bodkin @ mclean hospital, affiliate of harvard medical school, began collaboration somerset develop delivery of selegiline via transdermal patch in order avoid known dietary restrictions of mao inhibitors. somerset obtained fda approval market patch in 2006.
Comments
Post a Comment